<DOC>
	<DOCNO>NCT00626873</DOCNO>
	<brief_summary>RATIONALE : New diagnostic procedure , contrast-enhanced ultrasonography , may effective method find ovarian cancer . PURPOSE : This clinical trial study well contrast-enhanced ultrasonography work diagnose early-stage ovarian cancer patient adnexal mass undergoing surgery remove ovary .</brief_summary>
	<brief_title>Contrast-Enhanced Ultrasonography Diagnosing Early-Stage Ovarian Cancer Patients With Adnexal Mass Undergoing Surgery Remove Ovary</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether use contrast agent improve image ovary ultrasonography . OUTLINE : This multicenter study . Patients may undergo baseline transabdominal transvaginal ultrasonography , already do . Patients undergo contrast-enhanced transabdominal transvaginal ultrasonography use perflutren lipid microspheres ( Definity® ) IV . Pathology report tissue collect subsequent oophorectomy analyze compare ultrasonography finding .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis adnexal mass Scheduled undergo surgical oophorectomy PATIENT CHARACTERISTICS : Not pregnant nursing Negative pregnancy test No known respiratory failure manifest sign symptom carbon dioxide retention hypoxemia No pulmonary vasculitis No known history severe emphysema No known history pulmonary embolus No condition cause pulmonary hypertension due compromise pulmonary arterial vasculature No known history severe pulmonary hypertension ( i.e. , systolic pulmonary artery pressure &gt; 90 mm Hg ) No known history congenital heart defect create bidirectional righttoleft shunt No worsen clinically unstable congestive heart failure No known acute myocardial infarction acute coronary syndromes No know serious ventricular arrhythmia Not high risk arrhythmia due prolongation QT interval No known suspect hypersensitivity blood , blood product , albumin No known hypersensitivity perflutren No know suspect hypersensitivity octafluoropropane ingredient perflutren lipid microspheres ( Definity® ) No mental status problem , illiteracy , circumstance would preclude give informed consent PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>ovarian germ cell tumor</keyword>
	<keyword>ovarian epithelial cancer</keyword>
</DOC>